Smith Jason G, Cassany Aurelia, Gerace Larry, Ralston Robert, Nemerow Glen R
Department of Immunology and Microbial Science, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037, USA.
J Virol. 2008 Jul;82(13):6492-500. doi: 10.1128/JVI.00557-08. Epub 2008 Apr 30.
Neutralizing antibodies are commonly elicited by viral infection. Most antibodies that have been characterized block early stages of virus entry that occur before membrane penetration, whereas inhibition of late stages in entry that occurs after membrane penetration has been poorly characterized. Here we provide evidence that the neutralizing antihexon monoclonal antibody 9C12 inhibits adenovirus infection by blocking microtubule-dependent translocation of the virus to the microtubule-organizing center following endosome penetration. These studies identify a previously undescribed mechanism by which neutralizing antibodies block virus infection, a situation that may be relevant for other nonenveloped viruses that use microtubule-dependent transport during cell entry.
中和抗体通常由病毒感染引发。大多数已被鉴定的抗体可阻断病毒进入细胞的早期阶段,这些阶段发生在膜穿透之前,而对于膜穿透后发生的病毒进入后期阶段的抑制作用,目前了解甚少。在此,我们提供证据表明,中和性抗六邻体单克隆抗体9C12通过在内体穿透后阻断病毒依赖微管向微管组织中心的转运,从而抑制腺病毒感染。这些研究确定了一种以前未被描述的中和抗体阻断病毒感染的机制,这种情况可能与其他在细胞进入过程中利用微管依赖运输的非包膜病毒有关。